FindTrial
Sign In

A phase 2b study of M516102 in atopic dermatitis patients

A phase 2b study of M516102 in atopic dermatitis patients

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080221373
Enrollment
Unknown
Registered
2011-02-01
Start date
2011-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

investigational material(s) Generic name etc : M516102 INN of investigational material : Therapeutic category code : 449 Other antiallergic agents Dosage and Administration for Investigational materi

Sponsors

Maruho Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with atopic dermatitis 2. Outpatient

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Mean change in pruritus—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026